eHealthMe - FDA and Social Media, Personalized eHealthMe - FDA and Social Media, Personalized

FDA and Social Media, Personalized

Tools
Drugs A-Z       Conditions A-Z       Feature support groups

Home > Gleevec > Conjunctival haemorrhage > Gleevec and Conjunctival haemorrhage

Review: could Gleevec cause Conjunctival haemorrhage?

We study 20,252 people who have side effects while taking Gleevec from FDA and social media. Among them, 83 have Conjunctival haemorrhage. Find out below who they are, when they have Conjunctival haemorrhage and more.

Get connected: join a mobile support group for people who take Gleevec and have Conjunctival haemorrhage >>>

Gleevec

Gleevec (latest outcomes from 20,437 users) has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml).

Conjunctival haemorrhage

Conjunctival haemorrhage (bleeding underneath the conjunctiva) (latest reports from 8,957 patients) has been reported by people with onchocerciasis, multiple myeloma, osteoporosis, high blood pressure, depression.

On Oct, 29, 2014: 20,252 people reported to have side effects when taking Gleevec. Among them, 83 people (0.41%) have Conjunctival Haemorrhage.

Trend of Conjunctival haemorrhage in Gleevec reports

Time on Gleevec when people have Conjunctival haemorrhage * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years
Conjunctival haemorrhage20.59%35.29%23.53%0.00%5.88%14.71%0.00%

Gender of people who have Conjunctival haemorrhage when taking Gleevec * :

FemaleMale
Conjunctival haemorrhage75.22%24.78%

Age of people who have Conjunctival haemorrhage when taking Gleevec * :

0-12-910-1920-2930-3940-4950-5960+
Conjunctival haemorrhage0.00%0.00%0.00%0.00%8.99%15.73%11.24%64.04%

Severity of Conjunctival haemorrhage when taking Gleevec ** :

n/a

How people recovered from Conjunctival haemorrhage ** :

n/a

Top conditions involved for these people * :

  1. Chronic myeloid leukaemia (53 people, 63.86%)
  2. Gastrointestinal stromal tumour (14 people, 16.87%)
  3. Hypothyroidism (8 people, 9.64%)
  4. Chronic myeloid leukaemia (in remission) (6 people, 7.23%)
  5. Nausea (6 people, 7.23%)

Top co-used drugs for these people * :

  1. Vitamin d (11 people, 13.25%)
  2. Folic acid (10 people, 12.05%)
  3. Ambien (9 people, 10.84%)
  4. Atenolol (8 people, 9.64%)
  5. Lasix (8 people, 9.64%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Conjunctival Haemorrhage while taking Gleevec?

Get connected! Join a mobile support group:
- support group for people who take Gleevec and have Conjunctival Haemorrhage
- support group for people who take Gleevec
- support group for people who have Conjunctival Haemorrhage

Can you answer these questions (what is this?):

More questions for: Gleevec, Conjunctival haemorrhage

More reviews for: Gleevec, Conjunctival haemorrhage

On eHealthMe, Gleevec (imatinib mesylate) is often used for chronic myelogenous leukemia (cml). Find out below the conditions Gleevec is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.

What is Gleevec used for and how effective is it:

Other drugs that are used to treat the same conditions:

Drugs in real world that are associated with:

Could your condition cause it?

Related drug studies for: Gleevec, Conjunctival haemorrhage

Recent Gleevec related drug comparison:

More related comparison studies for: Gleevec, Conjunctival haemorrhage

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

44 million health professionals and patients have studied on eHealthMe. Recent studies:

- Amlodipine for a 67-year old woman who has CKD (35 minutes ago)

- Synthroid for a 11-year old girl who has Hypothyroidism (59 minutes ago)

- Oxybutynin Chloride for a 46-year old man who has Spinal Cord Injury Cervical (1 hour ago)

 

Recent mobile support groups

- Amlodipine

- Hypothyroidism and Impulsive Behaviour

- Impulsive Behaviour

- Synthroid

- Hypothyroidism

 

Recent user comments

- "She has never had any behavior problems until 2 month ... " (1 hour ago)

- "I've taken oxybutynin for 20+ years. Some 10 years ag ... " (1 hour ago)

- "hello, im not sure if l-lycine or l-arginine are re ... " (1 hour ago)

 

Recent searches

- Icp
- N Terminal Prohormone Brain Natriuretic Peptide
- Vitamin B Complex Deficiency
- Facial Tics
- Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride

   

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.